Moderna AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value decreased by 33.3% to $2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 81.8%, from $11.00M to $2.00M.
afs_trading_securities_unrealized_loss_12m_plus_fv| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $21.00M | $176.00M | $223.00M | $289.00M | $289.00M | $254.00M | $147.00M | $114.00M | $85.00M | $33.00M | $22.00M | $11.00M | $7.00M | $5.00M | $3.00M | $2.00M |
| QoQ Change | — | — | — | +738.1% | +26.7% | +29.6% | +0.0% | -12.1% | -42.1% | -22.4% | -25.4% | -61.2% | -33.3% | -50.0% | -36.4% | -28.6% | -40.0% | -33.3% |
| YoY Change | — | — | — | — | — | — | >999% | +44.3% | -34.1% | -60.6% | -70.6% | -87.0% | -85.0% | -90.4% | -91.8% | -84.8% | -86.4% | -81.8% |